Involvement of neutrophilic granulocytes in the uptake of biodegradable non-stealth and stealth nanoparticles in guinea pig

Biomaterials

Volumn 21, Issue 10, 2000, Pages 975-980

  Zambaux, Marie France ^a   Faivre Fiorina, Béatrice ^a   Bonneaux, François ^a   Marchal, Sophie ^a   Merlin, Jean Louis ^b   Dellacherie, Edith ^c   Labrude, P ^a   Vigneron, Claude ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b CENTRE ALEXIS VAUTRIN   (France)

^c LAB DE CHIM PHYS MACROMOLECULAIRE   (France)

Author keywords

Flow cytometry; Fluorescent nanoparticles; Guinea pig; Neutrophilic granulocytes; Phagocytosis

Indexed keywords

ANIMAL CELL CULTURE; BIODEGRADATION; COPOLYMERS; PHYSIOLOGICAL MODELS;

FLOW CYTOMETRY; FLUORESCENT NANOPARTICLES; NEUTROPHILIC GRANULOCYTES;

BIOMATERIALS;

COPOLYMER; METHOXY POLY(ETHYLENE OXIDE); NANOPARTICLE; POLYLACTIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; FLOW CYTOMETRY; GRANULOCYTE; GUINEA PIG; HISTOLOGY; MALE; NEUTROPHIL; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; SPLEEN;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; BIOLOGICAL TRANSPORT; FLOW CYTOMETRY; GUINEA PIGS; LACTIC ACID; MALE; NAPHTHACENES; NEUTROPHILS; PHAGOCYTOSIS; POLYETHYLENE GLYCOLS; POLYMERS; SPLEEN;

CAVIA PORCELLUS; SUS SCROFA;

EID: 0034017403     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(99)00233-1     Document Type: Article

References (23)

1. Oppenheim R.C. Solid colloidal drug delivery systems. nanoparticles Int J Pharm. 8:1981;217-234.
2. Allémann E., Gurny R., Doelker E. Drug loaded nanoparticles - preparation methods and drug targeting issues. Eur J Pharm Biopharm. 39:1993;173-191.
3. Ignatius A.A., Claes L.E. In vitro biocompatibility of bioresorbable polymers: poly(L,DL-lactide) and poly(L,DL-lactide-co-glycolide). Biomaterials. 17:1996;831-839.
4. Kim Y.I., Fluckiger L., Hoffman M., Lartaud-Idjouadienne I., Atkinson I., Maincent P. The antihypertensive effect of orally administered nifedipine-loaded nanoparticles in spontaneously hypertensive rats. Brit J Pharmacol. 120:1997;399-404.
5. Verrecchia T., Spenlehauer G., Bazile D.V., Murry-Brelier A., Archimbaud Y., Veillard M. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J Control Rel. 36:1995;49-61.
6. Fernandez-Urrusuno R., Fattal E., Rodrigues J.M. Jr., Féger J., Bedossa P., Couvreur P. Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice. J Biomed Mater Res. 31:1996;401-408.
7. Dunn S.E., Coombes A.G.A., Garnett M.C., Davis S.S., Illum L. In vitro cell interaction and in vivo distribution of poly(lactide-co-glycolide) nanosphere surface modified by poloxamer and poloxamine copolymers. J Control Rel. 44:1997;65-76.
8. Leu D., Manthey B., Kreuter J., Speiser P., De Luca P. Distribution and elimination of coated polymethyl [2-14C]methacrylate nanoparticles after intravenous injection in rats. J Pharm Sci. 73:1984;1433-1437.
9. Porter C.J., Davies M.C., Davis V., Illum L. Microparticulate systems for site-specific therapy-bone marrow targeting. 1994;Wiley, New York.
10. Bazile D, Michalon JP, Prud'homme C, Spenlehauer G, Veillard M. French Patent No. 08041, 1991.
11. Jeon S.I., Lee J.H., Andrade J.D., de Gennes P.G. Protein-surface interactions in the presence of polyethylene oxyde. J Colloid Interface Sci. 142:1991;149-166.
12. Vittaz M., Bazile D., Spenlehauer G., Verrecchia T., Veillard M., Puisieux F., Labarre D. Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. Biomaterials. 17:1996;1575-1581.
13. Zambaux M.F., Bonneaux F., Gref R., Dellacherie E., Vigneron C. MPEO-PLA nanoparticles. effect of MPEO content on some of their surface properties J Biomed Mater Res. 44:1999;109-115.
14. Bouillot P., Petit A., Dellacherie E. Protein encapsulation in biodegradable amphiphilic microspheres. I - Polymer synthesis and characterization and microspheres elaboration. J Appl Polym Sci. 68:1998;1695-1702.
15. Zambaux M.F., Bonneaux F., Gref R., Maincent P., Dellacherie E., Alonso M.J., Labrude P., Vigneron C. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Rel. 50:1998;31-40.
16. Gill S.K. New developments in chemiluminescence research. Aldrichimica Acta. 16:1983;59-61.
17. Brugère H, Laurent Le Bar JD, Malhouy G, Milhaud C, Schmitt S, Wintergest J. Expérimentation animale: mode d'emploi. Editions INSERM, Chimie et Ecologie, 1992.
18. Dresser R. Review standards for animal research. a closer book Ilar News. 32:1990;2-7.
19. Roux S., Carteaux J.P., Hess P., Falivene L., Clozel J.P. Experimental carotid thrombosis in the guinea pig. Thromb Haemostasis. 71:1994;252-256.
20. Manning P.J., Wagner E., Harkness J.E. Biology and diseases of guinea pigs. Fax J.G., Cohen B.J., Loew F.M. Laboratory animal medicine. 1984;149-181 Academic Press, New York.
21. Gibaud S., Demoy M., Andreux J.P., Weingarten C., Gouritin B., Couvreur P. Cells involved in the capture of nanoparticles in hematopoietic organs. J Pharm Sci. 85:1996;944-950.
22. Sang et systèmes de défense. In: Kahle W, Leonhardt H, Platzer W. editors. Frenche edition (C. Cabrol), Anatomie 2, Viscères, Flammarion-Medecine-Sciences, 1997. p. 82-103.
23. Demoy M., Gibaud S., Andreux J.P., Weingarten C., Gouritin B., Couvreur P. Splenic trapping of nanoparticles. complementary approaches for in situ studies Pharm Res. 14:1997;463-468.